A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2004
12/16/2004	CA2527323A1 Methods for predicting drug efficacy in patients afflicted with hypertension
12/16/2004	CA2527211A1 Anti-hiv benzamide compounds
12/16/2004	CA2527114A1 Methods for the protection of memory and cognition
12/16/2004	CA2526995A1 Bicyclic heterocycles, drugs containing said compounds, the use thereof and method for preparing the same
12/16/2004	CA2526792A1 Plasmid encoding fibroblast growth factor for the treatment of hypercholesterolemia or diabetes associated angiogenic defects
12/16/2004	CA2526694A1 Amidino compounds as cysteine protease inhibitors
12/16/2004	CA2526638A1 Method of mitigating the adverse effects of il-2
12/16/2004	CA2526506A1 Inhibitors of papilloma virus
12/16/2004	CA2526496A1 Use of hif alpha stabilizers for enhancing erythropoiesis
12/16/2004	CA2526007A1 Releasable polymeric conjugates based on aliphatic biodegradable linkers
12/16/2004	CA2525752A1 Cannabinoid receptor ligands and uses thereof
12/16/2004	CA2524381A1 Nutritional composition and method of inhibiting smooth muscle cell contraction thereof
12/16/2004	CA2524376A1 Substituted imidazolopyrazine and triazolopyrazyne derivatives: gabaa receptor ligands
12/15/2004	EP1486565A1 Combination PDGF, KGF, IGF, and IGFBP for wound healing
12/15/2004	EP1486504A1 Nucleoside analogues whose sugar moieties are bound in s-form and oligonucleotide derivatives comprising nucleotide analogues thereof
12/15/2004	EP1486503A1 Derivatives of benzothiazine and benzothiadiazine, procedure for their preparation and pharmaceutical compositions containing them
12/15/2004	EP1486502A1 Derivatives of benzothiazine and benzothiadiazine, procedure for their preparation and pharmaceutical compositions containing them
12/15/2004	EP1486501A1 Aminomethyl-substituted thiazolobenzimidazole derivative
12/15/2004	EP1486497A1 Novel pyridone derivative
12/15/2004	EP1486496A1 Substituted 2-(2,6-Dioxopiperidin-3-YP)-Phthalimides and 1-Oxoisoindolines and method fo reducing TNF alpha levels
12/15/2004	EP1486495A1 Lipoic acid derivatives and their use in treatment of disease
12/15/2004	EP1486487A1 Position-4 substituted 2-pyrrolidinone derivatives to reduce the level of extracellular glutamate
12/15/2004	EP1486486A2 Substituted B-thiocarboxylic acids
12/15/2004	EP1486213A1 The use of the total coumarins of cnidium monnieri in preparation of the medicament for treating psoriasis
12/15/2004	EP1486212A1 Combination of a mutant herepes virus and irinotecan for the treatment of cancer
12/15/2004	EP1486210A1 Pyrimidine nucleotide precursors for treatment of inflammatory hepatitis
12/15/2004	EP1486209A2 Pharmaceutical formulations for the treatment of inflammatory bowel disease
12/15/2004	EP1486208A1 Novel preventive for infections
12/15/2004	EP1486207A2 Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same
12/15/2004	EP1486206A1 New uses for amino acid anticonvulsants for treatment of bipolare disorder
12/15/2004	EP1486205A1 New uses for amino acid anticonvulsants for treatment of migraine
12/15/2004	EP1486203A2 Surfactant compounds and uses thereof
12/15/2004	EP1485709A1 Therapeutic methods employing pai-1 inhibitors and transgenic non-human animal for screening candidate pai-1 inhibitors
12/15/2004	EP1485472A2 Crystal structure of an aurora kinase catalytic domain, and uses thereof
12/15/2004	EP1485403A2 Compositions and methods to initiate or enhance antibody and major-histocompatibility class i or class ii-restricted t cell responses by using immunomodulatory, non-coding rna motifs
12/15/2004	EP1485401A1 Trpm-2 antisense therapy using an oligonucleotide having 2'-o-(-2-methoxyl)ethyl modifications
12/15/2004	EP1485396A2 Nucleoside 5'-monophosphate mimics and their prodrugs
12/15/2004	EP1485395A2 Nucleotide mimics and their prodrugs
12/15/2004	EP1485394A1 Process for isolation of eupalitin (3-o-beta-d-galactopyranoside) from boerhavia diffusa
12/15/2004	EP1485393A2 9-dexo-9a-aza-9a-methyl-9a-homoerythromycin a derivatives
12/15/2004	EP1485391A2 Phosphate transport inhibitors
12/15/2004	EP1485390A1 Bicyclic pyridine and pyrimidine p38 kinase inhibitors
12/15/2004	EP1485389A1 Antiparasitic artemisinin derivatives (endoperoxides)
12/15/2004	EP1485388A2 Topiramate salts and compositions comprising and methods of making and using the same
12/15/2004	EP1485387A1 Carbamates as hiv protease inhibitors
12/15/2004	EP1485385A1 Pyrazolopyrimidine and pyrazolotriazine derivatives and pharmaceutical compositions containing them
12/15/2004	EP1485384A1 Pyrazolo(1,5-a)pyridine derivatives as neurotransmitter modulators
12/15/2004	EP1485383A1 Process for preparing crystalline form i of cabergoline
12/15/2004	EP1485381A1 Azolylaminoazine as inhibitors of protein kinases
12/15/2004	EP1485379A1 Beta 3-adrenergic receptor agonists
12/15/2004	EP1485378A1 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
12/15/2004	EP1485377A1 Pyranones useful as atm inhibitors
12/15/2004	EP1485375A1 Pyrimidine compounds
12/15/2004	EP1485374A1 Pyrimidine compounds
12/15/2004	EP1485373A1 Method of stabilizing lansoprazole
12/15/2004	EP1485371A2 Indole amide derivatives and their use as glycogen phosphorylase inhibitors
12/15/2004	EP1485370A1 Amino-derivatives as novel inhibitors of histone deacetylase
12/15/2004	EP1485368A1 Substituted chroman derivatives having cytochrome p450rai inhibitory activity
12/15/2004	EP1485365A1 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
12/15/2004	EP1485364A1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
12/15/2004	EP1485363A1 Cyclic amides
12/15/2004	EP1485362A1 Crystalline parecoxib sodium
12/15/2004	EP1485360A2 Sodium channel blockers
12/15/2004	EP1485359A2 Sodium channel blockers
12/15/2004	EP1485358A1 Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors
12/15/2004	EP1485356A1 NON-PEPTIDE GnRH ANTAGONISTS
12/15/2004	EP1485354A1 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
12/15/2004	EP1485353A1 New inhibitors of histone deacetylase
12/15/2004	EP1485352A1 Azaspiro compounds for the treatment of pain
12/15/2004	EP1485349A1 Formulations of anthraquinone derivatives
12/15/2004	EP1485348A1 Carbonylamino-derivatives as novel inhibitors of histone deacetylase
12/15/2004	EP1485347A2 Hif hydroxylase inhibitors
12/15/2004	EP1485344A1 Venlafaxine besylate
12/15/2004	EP1485343A1 Amorphous hmg-coa reductase inhibitors of desired particle size
12/15/2004	EP1485339A2 Benzyl alcohol derivatives and their use as antimicrobial agents
12/15/2004	EP1485338A1 Alkoxy-substituted indanes and the production thereof
12/15/2004	EP1485168A1 Combination of a cdk inhibitor and 5-fu for the treatment of cancer
12/15/2004	EP1485167A1 1,2-dihydropyrazol-3-ones as cytokine mediators
12/15/2004	EP1485160A1 Intraductal management of breast lesions involving therapeutic or diagnostic agents
12/15/2004	EP1485145A1 Multiple compartment bag assembly for dialysis fluid
12/15/2004	EP1485138A1 Medical device for delivering biologically active material
12/15/2004	EP1485132A2 Combination of an aldosterone receptor antagonist and a fibric acid derivative
12/15/2004	EP1485131A1 Matrix metalloproteinase inhibitors in combination with hypothermia and/or radiotherapy for the treatment of cancer
12/15/2004	EP1485127A2 Administration of agents for the treatment of inflammation
12/15/2004	EP1485121A2 Activated protein c formulations
12/15/2004	EP1485115A2 Oligo(ethylene glycol)-terminated 1,2-dithiolanes and their conjugates useful for preparing self-assembled monolayers
12/15/2004	EP1485114A2 Isolation, purification and structural identification of a bioactive component of a water soluble extract of a botanical species for enhancing immune, anti-inflammatory, anti-tumor and dna repair processes of warm blooded animals
12/15/2004	EP1485110A1 Use of sulfoalkyl ether cyclodextrin as a preservative
12/15/2004	EP1485109A1 Vascular therapeutics
12/15/2004	EP1485106A2 Phosphonate-phosphate and diphosphonate apolipoprotein e modulators
12/15/2004	EP1485105A1 Combination of an aldosterone receptor antagonist and a bile acid sequestering agent
12/15/2004	EP1485104A1 Combination of an aldosterone receptor antagonist and nicotinic acid or a nicotinic acid derivative
12/15/2004	EP1485103A1 Sulfatase inhibiting continuous progestogen contraceptive regimens
12/15/2004	EP1485102A2 Sequential therapy comprising a 20(s)-camptothecin compound and a pyrimidine base analog
12/15/2004	EP1485101A1 Non-sedating barbituric acid derivatives
12/15/2004	EP1485100A1 Azinylaminoazoles as inhibitors of protein kinases
12/15/2004	EP1485099A1 Inhibitors of histone deacetylase
12/15/2004	EP1485098A1 Pharmaceutical compositions comprising 2-(4-ethoxy-phenyl)-3-(4-methanesulfonyl-phenyl)-pyrazolo[1,5-b]pyridazine in nanoparticulate form
12/15/2004	EP1485097A1 Crystalline forms of gatifloxacin and processes for preparation
12/15/2004	EP1485096A2 Methods for preventing or treating cardiac arrhythmia

1 ... 4858 4859 4860 4861 4862 4863 4864 4865 4866 4867 4868 4869 4870 4871 4872 4873 4874 4875 4876 4877 4878 ... 7860